Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VIS
|
|||
| Former ID |
DNAP001442
|
|||
| Drug Name |
Andrographolide
|
|||
| Synonyms |
Andrographolide; 5508-58-7; Andrographis; UNII-410105JHGR; CHEBI:65408; 410105JHGR; (S,E)-4-Hydroxy-3-(2-((1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethylidene)dihydrofuran-2(3H)-one; AK-47364; 3-(2-(Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-one; EINECS 226-852-5; NSC 383468; 3alpha,14,15,18-tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic acid gamma-Lactone
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bacillary dysentery [ICD-11: 1A02] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H30O5
|
|||
| Canonical SMILES |
CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)CO)O
|
|||
| InChI |
1S/C20H30O5/c1-12-4-7-16-19(2,9-8-17(23)20(16,3)11-21)14(12)6-5-13-15(22)10-25-18(13)24/h5,14-17,21-23H,1,4,6-11H2,2-3H3/b13-5+/t14-,15-,16+,17-,19+,20+/m1/s1
|
|||
| InChIKey |
BOJKULTULYSRAS-OTESTREVSA-N
|
|||
| CAS Number |
CAS 5508-58-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
598321, 11057877, 12015867, 12161640, 14851955, 16378642, 39292544, 47583570, 48328893, 50124542, 50966282, 53790942, 85842841, 88784123, 93165982, 95154435, 103450592, 114172053, 126669760, 135023123, 135683630, 136374610, 139065361, 140862479, 144205061, 152059494, 160644838, 162035636, 163311957, 163614395, 165235844, 174478337, 175423057, 175607906, 184812326, 196381491, 198952381, 210280232, 210282211, 211534823, 221672629, 223555823, 223753076, 237172992, 249834841, 250178438, 250197243, 251897984, 251911763, 251914841
|
|||
| ChEBI ID |
CHEBI:65408
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.